The participation of people deprived of liberty in tuberculosis vaccine trials: should they be protected from research, or through research?
Year: 2025
Type: article
Source: The Lancet Infectious Diseases
Authors: Jason R Andrews, Salome Charalambous, Gavin Churchyard, Frank Cobelens, Carlos Fernández-Escobar, Mike Frick, Willem Hanekom, Mark Hatherill, Philip C Hill, Surabhi Pandey, Molebogeng X Rangaka, Richard G White, Everton F Lemos, Alessandra Moura da Silva, Julio Croda, Alberto L Garcia-Basteiro
Institutions: Stanford University, University of the Witwatersrand, Vanderbilt University, Aurum Institute, Amsterdam Institute for Global Health and Development, Amsterdam University Medical Centers, University of Amsterdam, Barcelona Institute for Global Health, Universitat de Barcelona, Treatment Action Group, Africa Health Research Institute, University College London, University of Cape Town, Institute of Infectious Disease and Molecular Medicine, University of Otago, MRC Clinical Trials Unit at UCL, Wellcome Centre for Infectious Diseases Research in Africa, London School of Hygiene & Tropical Medicine, Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Universidade Federal de Mato Grosso do Sul, Yale University, Centro de Investigación Biomédica en Red, Hospital Clínic de Barcelona, Manhiça Health Research Centre
Language: English
Topic: Ethics in Clinical Research
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4411922270